C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/24/2002	US20020155451 Detecting mutation in sample; obtain nucleotide sequences, incubate with primer, hybridize, cleave nucleotide sequences, remove segments, detect mutation
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155446 Very low density lipoprotein receptor polymorphisms and uses therefor
10/24/2002	US20020155444 Neuronal protein for use in the treatment of psychiatric, nervous system, sleep and fertility disorders
10/24/2002	US20020155442 Detecting nanoparticle linked nucleotide sequences; obtain nucleotide sequences, incubate with oligonucleotides, detect hybridization
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155439 Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction
10/24/2002	US20020155438 Detecting preferential open reading frames in sample; obtain sample of nucleotide sequences, obtain single stranded cDNA, amplify, sequencing nucleotid sequences
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/24/2002	US20020155431 Screenining and detection of antiproliferative agentst; obtain tumor cells, incubate with antiproliferative agents, monitor reduction in tumor activity
10/24/2002	US20020155430 Lentiviral vector system for high quantity screening
10/24/2002	US20020155428 Retrovirus from the HIV group and its use
10/24/2002	US20020155427 Detecting preferential microorganism in sample; obtain nucleotide sequences, incubate with primers, amplify, compare to control, classify microoganism
10/24/2002	US20020155192 Yeast transport isoforms
10/24/2002	US20020155157 Compositions and methods for polynucleotide delivery
10/24/2002	US20020155130 To immunity to mammals from infection and/or disease caused by a lentivirus, such as equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus, bovine immunodeficiency virus or simian immunodeficiency virus
10/24/2002	US20020155127 Genetic vaccine against human immunodeficiency virus
10/24/2002	US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	US20020155110 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them
10/24/2002	US20020155104 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites
10/24/2002	US20020155102 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
10/24/2002	US20020155101 Cardiac arrhythmia treatment methods
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	US20020155095 Introducing into tissue of interest recombinant vector comprising nucleic acid segment encoding interferon alpha polypeptide, nucleic acid segment being operatively linked to a promoter having specificity for tissue of interest
10/24/2002	US20020155084 Nanoemulsion formulations
10/24/2002	US20020153435 Liquid discharge apparatus for producing probe carrier, apparatus for producing probe carrier and method for producing probe carrier
10/24/2002	US20020153251 Introducing a photopolymerizable material in an intersection formed between a first and second microchannel in device, and forming a localized gel by photopolymerization at intersection, wherein gel acts to create barrier to flow
10/24/2002	DE10119999A1 Identifying agents that modulate cellular transport, processing and secretion processes, useful as lead compounds for development of therapeutic and diagnostic compounds
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	DE10119901A1 Apparatus for electrophoretic transfer of biologically active molecules into cells comprises capacitors connected to high voltage sources, which discharge via power transistor into cuvette holding sample
10/24/2002	DE10119432A1 New nucleic acid encoding flavone synthase I, useful e.g. for preparing transgenic plants with altered flavone content, also derived enzyme used for flavone production
10/24/2002	DE10119294A1 New tumor-associated antigen B345, useful for diagnosis and immunotherapy of tumors, also related nucleic acid and antibodies
10/24/2002	DE10119006A1 Verfahren zur Verbesserung der Stabilität linearer DNA in zellfreien in vitro Transkriptions/Translations-Systemen A method for improving the stability of linear DNA in cell-free in vitro transcription / translation systems
10/24/2002	DE10119005A1 Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen A process for protein expression from stabilized linear short DNA comprising, in cell-free in vitro transcription / translation systems using exonuclease-containing lysates or in a cellular system exonucleases
10/24/2002	DE10117858A1 New major histocompatibility complex tetramer, useful for studying the antigen-specific immune response, includes DsRed fluorescent protein as tetramerizing agent
10/24/2002	DE10113604A1 Verfahren zur Spaltung des humanen Wachstumshormons GH A process for cleavage of human growth hormone GH
10/24/2002	CA2747868A1 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
10/24/2002	CA2456736A1 Compositions and methods for the production of betaine lipids
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2445626A1 Mosaic adenoviral vectors
10/24/2002	CA2445029A1 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	CA2444840A1 Akt and regulation of ra synovial fibroblast apoptosis
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444482A1 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002	CA2444451A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002	CA2444298A1 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444174A1 Universal multi-variant detection system
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444087A1 Plant growth regulating genes, proteins and uses thereof
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	CA2444001A1 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	CA2443999A1 Methods and compositions for nucleotide analysis
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443984A1 Encapsulated cell indicator system
10/24/2002	CA2443968A1 Diagnosis and treatment of cancer: i
10/24/2002	CA2443923A1 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	CA2443908A1 Product and process for transformation of thraustochytriales microorganisms
10/24/2002	CA2443903A1 Antibodies to vla-1
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	CA2443842A1 Methods of analysis and labeling of protein-protein interactions
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443736A1 Insect ammunition vectors and methods of use to identify pesticide targets
10/24/2002	CA2443732A1 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	CA2443711A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002	CA2443705A1 Cyclic single strand trispecific antibody
10/24/2002	CA2443570A1 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443295A1 Novel endophytic fungi and methods of use
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443122A1 Mobility-modified nucleobase polymers and methods of using same
10/24/2002	CA2442819A1 Elimination of endogenous porcine retrovirus
10/24/2002	CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	CA2442670A1 Method of treating or retarding the development of blindness
10/24/2002	CA2442264A1 A method of treating cancer
10/24/2002	CA2441876A1 Production of apomictic seed
10/24/2002	CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	CA2440846A1 Protein cluster v
10/24/2002	CA2440146A1 P450 single nucleotide polymorphism biochip analysis
10/24/2002	CA2439401A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2437280A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	CA2430322A1 Use of clya hemolysin for excretion of proteins
10/23/2002	EP1251352A2 Reaction apparatus and its use in a method of analyzing biologically active substances
10/23/2002	EP1251179A2 Method for protein expression starting from stabilized linear short DNA in cell-free in vitro transcription/translation systems with exonuclease-containing lysates or in a cellular system containing exonucleases
10/23/2002	EP1251178A1 Novel polypeptide-human shc protein 43 and polynucleotide encoding it

1 ... 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 ... 4023